Strategic Partnership ABX is a global frontrunner in radiopharmaceuticals with GMP production capabilities, in-house sterility testing, and aseptic excipients. This creates strong opportunities for partnerships with pharma and biotech firms seeking reliable radiopharmaceutical supply, turnkey kit development, and integrated manufacturing solutions.

Expansion Readiness Recent leadership change and established R&D hot lab indicate ongoing strategic focus and stability. Position ABX as a preferred supplier for expanding PET/SPECT programs, radiopharmaceutical kits, and new tracer development in collaborations with research institutions and startups.

End-to-End Control In-house production of precursors, kits, cassettes, and sterile disposables reduces dependency on external sourcing. Market ABX as a one-stop source for complete radiopharmaceutical drug production, appealing to companies seeking streamlined supply and quality assurance.

Regulatory Expertise Expertise in ASMFs, US-DMFs, and comprehensive documentation for reagent kits and radiopharmaceuticals positions ABX to support clients pursuing global approvals and market access, offering consulting and compliant manufacturing services.

Collaborative Opportunities Past exclusivity agreements and partnerships related to Re-186 NanoLiposome suggest ABX is open to long-term collaborations for key radiotherapeutics. Target researchers and companies developing radiopharmacological programs that require scalable production and co-development.